Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Gastrointestinal luminal gas is a complex mixture of gases—predominantly nitrogen, hydrogen, carbon dioxide, methane, and oxygen—found within the digestive tract (StatPearls, 2023). These gases are produced through several mechanisms, including aerophagia (swallowing air), intraluminal chemical reactions, and the metabolic activity of the gut microbiota during the fermentation of dietary fibers (PubMed, PMID: 30060924). In healthy individuals, gas volume is regulated through eructation, absorption into the bloodstream, and flatulence; however, dysregulation or excessive production is a hallmark of functional gastrointestinal disorders like irritable bowel syndrome (IBS) and small intestinal bacterial overgrowth (SIBO) (NIH, 2022). Pharmacological management often targets the physical state of these gases; for instance, simethicone acts as a surfactant to reduce the surface tension of small gas bubbles, allowing them to merge into larger bubbles that are more easily expelled (NCBI, NBK555931). Other therapeutic approaches include the use of enzymes like alpha-galactosidase to prevent gas formation by breaking down non-digestible oligosaccharides before they reach gas-producing colonic bacteria (PubMed, PMID: 17151807).
Reduction of surface tension of gas bubbles to facilitate coalescence and expulsion (anti-foaming agent) or enzymatic degradation of gas-producing substrates.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gastrointestinal luminal gas.